[Generation of human iPS cell-derived hepatocytes and enterocytes for application to drug disposition studies]

Nihon Yakurigaku Zasshi. 2019;154(2):72-77. doi: 10.1254/fpj.154.72.
[Article in Japanese]


In drug disposition, the liver and small intestine are very important as tissues involving in drug metabolism, absorption, and excretion. Thus, in drug development studies, it is necessary to evaluate the pharmacokinetics in these tissues accurately including the contributions of drug-metabolizing enzymes and drug transporters. Currently, all kinds of evaluation systems have been used for the pharmacokinetic prediction; however, there are some issues in these systems. Therefore, the researches for the development of human induced pluripotent stem (iPS) cell-derived hepatocytes and enterocytes, as novel systems besides existing ones, are being advanced. Because human iPS cells have abilities of pluripotency and almost infinite proliferation, it is thought to be possible to stably provide the high-quality cells that have similar characteristics to human normal tissue cells by using human iPS cells. In this review, we describe current status of differentiation studies of human iPS cell-derived hepatocytes and enterocytes and the functional characteristics of these cells centered on pharmacokinetic functions.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Drug Evaluation, Preclinical
  • Enterocytes / cytology
  • Enterocytes / drug effects*
  • Hepatocytes / cytology
  • Hepatocytes / drug effects*
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / drug effects*
  • Intestine, Small
  • Liver
  • Pharmacokinetics